The Russian anti-COVID19 vaccine Sputnik V is registered in the Republic of Panama, according to the Russian Direct Investment Fund (RDIF).
Thus, the drug is approved in 59 countries with a total population of over 1.5 billion people. Registration of the drug was carried out as part of an accelerated procedure (emergency use authorization, EUA).
In terms of the number of approvals received by state regulators, Sputnik V ranks second in the world.
“The decision of the Panama regulatory authorities to approve the Sputnik V vaccine will ensure access of the country’s population to a safe and effective Russian vaccine. Sputnik V is recognized around the world and is one of the leading vaccines to combat coronavirus and overcome the pandemic, “said Kirill Dmitriev, CEO of the RDIF.
Currently, the use of the Sputnik V vaccine has also been approved in Russia, Belarus, Argentina, Bolivia, Serbia, Algeria, Palestine, Venezuela, Paraguay, Turkmenistan, Hungary, the UAE, Iran, the Republic of Guinea, Tunisia, Armenia, Mexico, Nicaragua, Republika Srpska (entity of Bosnia and Herzegovina), Lebanon, Myanmar, Pakistan, Mongolia, Bahrain, Montenegro, Saint Vincent and the Grenadines, Kazakhstan, Uzbekistan, Gabon, San Marino, Ghana, Syria, Kyrgyzstan, Guyana, Egypt, Honduras, Guatemala, Moldova, Slovakia, Angola, Djibouti, Republic of the Congo, Sri Lanka, Laos, Iraq, North Macedonia, Kenya, Morocco, Jordan, Namibia, Azerbaijan, Philippines, Cameroon, Seychelles, Mauritius, Vietnam, Antigua and Barbuda and Mali.